Skalniak Lukasz, Mizgalska Danuta, Zarebski Adrian, Wyrzykowska Paulina, Koj Aleksander, Jura Jolanta
Department of Cell Biochemistry, Faculty of Biochemistry, Jagiellonian University, Krakow, Poland.
FEBS J. 2009 Oct;276(20):5892-905. doi: 10.1111/j.1742-4658.2009.07273.x. Epub 2009 Sep 11.
A novel gene ZC3H12A, encoding MCP-1-induced protein 1 (MCPIP), was recently identified in human peripheral blood monocytes treated with monocyte chemotactic protein 1 (MCP-1) and in human monocyte-derived macrophages stimulated with interleukin (IL)-1beta. These experiments revealed that the gene undergoes rapid and potent transcription induction upon stimulation with proinflammatory molecules, such as MCP-1, IL-1beta, tumour necrosis factor alpha and lipopolysaccharide. Here we show that the induction of ZC3H12A by IL-1beta is predominantly NF-kappaB-dependent because inhibition of this signalling pathway results in the impairment of ZC3H12A transcription activation. Our results indicate the presence of an IL-1beta-responding region within the second intron of the ZC3H12A gene, which contains four functional NF-kappaB-binding sites. Therefore, we propose that this transcription enhancer transduces a ZC3H12A transcription-inducing signal after IL-1beta stimulation. Recent reports suggest that MCPIP acts as a negative regulator of inflammatory processes because it is engaged in the degradation of transcripts coding for certain proinflammatory cytokines. Our observations provide evidence for a novel negative feedback loop in the activation of NF-kappaB and point to potential significance of MCPIP in the treatment of various pathological states, such as diabetes or cancer that involve disturbances in the functioning of the NF-kappaB system.
一种编码单核细胞趋化蛋白-1诱导蛋白1(MCPIP)的新基因ZC3H12A,最近在经单核细胞趋化蛋白1(MCP-1)处理的人外周血单核细胞以及用白细胞介素(IL)-1β刺激的人单核细胞衍生巨噬细胞中被鉴定出来。这些实验表明,在用促炎分子如MCP-1、IL-1β、肿瘤坏死因子α和脂多糖刺激后,该基因会经历快速且强烈的转录诱导。在此我们表明,IL-1β对ZC3H12A的诱导主要依赖于核因子κB(NF-κB),因为抑制该信号通路会导致ZC3H12A转录激活受损。我们的结果表明,在ZC3H12A基因的第二个内含子内存在一个IL-1β反应区域,该区域包含四个功能性NF-κB结合位点。因此,我们提出这个转录增强子在IL-1β刺激后转导一个ZC3H12A转录诱导信号。最近的报道表明,MCPIP作为炎症过程的负调节因子,因为它参与编码某些促炎细胞因子的转录本的降解。我们的观察结果为NF-κB激活中的一种新型负反馈回路提供了证据,并指出了MCPIP在治疗各种病理状态(如涉及NF-κB系统功能紊乱的糖尿病或癌症)中的潜在意义。